EU countries are in no hurry to waive vaccine patents

Waiving patents may be a solution in the long term but does not generate more vaccines now, say EU countries.

President of the European Council Charles Michel | Photo: POOL/REUTERS / X80003

EU member countries are ready to look into whether the EU should waive covid-19 vaccine patents.

However, this is no urgent matter, as the patents are not what is currently preventing developing countries from getting vaccines more quickly, according to an informal meeting of the members of the European Council in Porto.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs